Sancusco granistron patch: Phase I started

Solasia began a U.S. Phase I trial to evaluate Sancuso granisetron patch (SP-01) in healthy Japanese volunteers. Solasia (formerly JapanBridge K.K.) has rights to Sancuso in Japan, China, Taiwan, S...